SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-23
👔
FibroBiologics, Inc.
@FBLG_InsiderForm 4 Filing: Niklas Victoria Ninon Olivia Acquires (Grant) shares of $FBLG
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
FibroBiologics, Inc.
Ticker: $FBLG
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-23
Shares: 30,803
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Niklas Victoria Ninon Olivia, holds the title of Director at FibroBiologics, Inc..
On 2026-06-23, the insider transacted 30,803 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Niklas Victoria Ninon Olivia (Director) was granted $0 of $FBLG
Post-Transaction Position: 30,803 shares
SEC Accession No: 0001493152-26-029848 (CIK: 2012250)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.